Blood Pressure: New Evidence New Targets

Research output: Contribution to journalEditorialResearchpeer-review

Abstract

[Extract]
Raised blood pressure, along with smoking and raised cholesterol levels, is a key
modifiable risk factor for cardiovascular (CV) disease in people with diabetes. “Hypertension” is in fact not a clinical disease in itself, in that individuals with raised blood pressure do not generally have symptoms, but rather have a risk factor for CV disease. There is no discrete boundary that defines the hypertensive state from the non-hypertensive one, and judgment is required to determine the diagnostic threshold (if one is used) and to determine target BP levels for treatment. Clinical guidelines have progressively lowered the threshold for diagnosing “hypertension” in both people with and without diabetes, from the 1970s definition of having a systolic blood pressure (SBP) of 160mmHg or diastolic blood pressure (DBP) of 95mmHg, to a SBP of 140mmHg or DBP of 90mmHg.
Original languageEnglish
Pages (from-to)24-27
Number of pages3
JournalDiabetes Management Journal
VolumeMay 2019
Publication statusPublished - May 2019

Fingerprint

Blood Pressure
Cardiovascular Diseases
Hypertension
Smoking
Cholesterol
Guidelines

Cite this

@article{5c1ad3170058417f8838b9fb10636ce5,
title = "Blood Pressure: New Evidence New Targets",
abstract = "[Extract] Raised blood pressure, along with smoking and raised cholesterol levels, is a keymodifiable risk factor for cardiovascular (CV) disease in people with diabetes. “Hypertension” is in fact not a clinical disease in itself, in that individuals with raised blood pressure do not generally have symptoms, but rather have a risk factor for CV disease. There is no discrete boundary that defines the hypertensive state from the non-hypertensive one, and judgment is required to determine the diagnostic threshold (if one is used) and to determine target BP levels for treatment. Clinical guidelines have progressively lowered the threshold for diagnosing “hypertension” in both people with and without diabetes, from the 1970s definition of having a systolic blood pressure (SBP) of 160mmHg or diastolic blood pressure (DBP) of 95mmHg, to a SBP of 140mmHg or DBP of 90mmHg.",
author = "Katy Bell and Loai Albarqouni and Jenny Doust",
year = "2019",
month = "5",
language = "English",
volume = "May 2019",
pages = "24--27",
journal = "Diabetes Management Journal",

}

Blood Pressure: New Evidence New Targets. / Bell, Katy; Albarqouni, Loai; Doust, Jenny.

In: Diabetes Management Journal, Vol. May 2019, 05.2019, p. 24-27.

Research output: Contribution to journalEditorialResearchpeer-review

TY - JOUR

T1 - Blood Pressure: New Evidence New Targets

AU - Bell, Katy

AU - Albarqouni, Loai

AU - Doust, Jenny

PY - 2019/5

Y1 - 2019/5

N2 - [Extract] Raised blood pressure, along with smoking and raised cholesterol levels, is a keymodifiable risk factor for cardiovascular (CV) disease in people with diabetes. “Hypertension” is in fact not a clinical disease in itself, in that individuals with raised blood pressure do not generally have symptoms, but rather have a risk factor for CV disease. There is no discrete boundary that defines the hypertensive state from the non-hypertensive one, and judgment is required to determine the diagnostic threshold (if one is used) and to determine target BP levels for treatment. Clinical guidelines have progressively lowered the threshold for diagnosing “hypertension” in both people with and without diabetes, from the 1970s definition of having a systolic blood pressure (SBP) of 160mmHg or diastolic blood pressure (DBP) of 95mmHg, to a SBP of 140mmHg or DBP of 90mmHg.

AB - [Extract] Raised blood pressure, along with smoking and raised cholesterol levels, is a keymodifiable risk factor for cardiovascular (CV) disease in people with diabetes. “Hypertension” is in fact not a clinical disease in itself, in that individuals with raised blood pressure do not generally have symptoms, but rather have a risk factor for CV disease. There is no discrete boundary that defines the hypertensive state from the non-hypertensive one, and judgment is required to determine the diagnostic threshold (if one is used) and to determine target BP levels for treatment. Clinical guidelines have progressively lowered the threshold for diagnosing “hypertension” in both people with and without diabetes, from the 1970s definition of having a systolic blood pressure (SBP) of 160mmHg or diastolic blood pressure (DBP) of 95mmHg, to a SBP of 140mmHg or DBP of 90mmHg.

UR - https://www.diabetesaustralia.com.au/diabetes-management-journal

M3 - Editorial

VL - May 2019

SP - 24

EP - 27

JO - Diabetes Management Journal

JF - Diabetes Management Journal

ER -